XML 53 R35.htm IDEA: XBRL DOCUMENT
v3.10.0.1

STOCKHOLDERS' DEFICIT (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2018
Equity [Abstract] |
Schedule of Changes in Shareholders' Deficit | The following table shows the changes in stockholders' deficit attributable to the Company and the noncontrolling interests of subsidiaries in which the Company has a majority, but not total, ownership interest:
(In thousands) | The Company |  | Noncontrolling Interests |  | Consolidated
Balances as of January 1, 2018 | $ | (11,385,535 | ) |  | $ | 41,191 |  |  | $ | (11,344,344 | )
Net loss | (201,910 | ) |  | (729 | ) |  | (202,639 | )
Dividends and other payments to noncontrolling interests | — |  |  | (8,742 | ) |  | (8,742 | )
Share-based compensation | 2,066 |  |  | 8,517 |  |  | 10,583 |
Foreign currency translation adjustments | (7,161 | ) |  | (8,763 | ) |  | (15,924 | )
Other adjustments to comprehensive loss | (1,250 | ) |  | (248 | ) |  | (1,498 | )
Reclassifications adjustments | 2,664 |  |  | 298 |  |  | 2,962 |
Other, net | (84 | ) |  | (656 | ) |  | (740 | )
Balances as of December 31, 2018 | $ | (11,591,210 | ) |  | $ | 30,868 |  |  | $ | (11,560,342 | )
(In thousands) | The Company |  | Noncontrolling Interests |  | Consolidated
Balances as of January 1, 2017 | $ | (11,030,835 | ) |  | $ | 128,974 |  |  | $ | (10,901,861 | )
Net loss | (398,060 | ) |  | (60,651 | ) |  | (458,711 | )
Dividends and other payments to noncontrolling interests | — |  |  | (46,151 | ) |  | (46,151 | )
Purchase of additional noncontrolling interests | (524 | ) |  | (703 | ) |  | (1,227 | )
Disposal of noncontrolling interests | — |  |  | (2,439 | ) |  | (2,439 | )
Share-based compensation | 2,488 |  |  | 9,590 |  |  | 12,078 |
Foreign currency translation adjustments | 31,244 |  |  | 12,607 |  |  | 43,851 |
Unrealized holding loss on marketable securities | (370 | ) |  | (44 | ) |  | (414 | )
Other adjustments to comprehensive loss | 6,013 |  |  | 707 |  |  | 6,720 |
Reclassifications adjustments | 4,864 |  |  | 577 |  |  | 5,441 |
Other, net | (355 | ) |  | (1,276 | ) |  | (1,631 | )
Balances as of December 31, 2017 | $ | (11,385,535 | ) |  | $ | 41,191 |  |  | $ | (11,344,344 | )
The following table discloses the increase (decrease) in other comprehensive income (loss) related to deferred income tax liabilities for the years ended December 31, 2018, 2017 and 2016, respectively:
(In thousands) | Years Ended December 31,
| 2018 |  | 2017 |  | 2016
Pension adjustments and other | $ | 730 |  |  | $ | (314 | ) |  | $ | (1,044 | )
Total (increase) decrease in deferred tax liabilities | $ | 730 |  |  | $ | (314 | ) |  | $ | (1,044 | )
Schedule of Stock Options Outstanding and Stock Option Activity | The following table presents a summary of CCOH’s stock options outstanding at and stock option activity during the year ended December 31, 2018:
(In thousands, except per share data) | Options |  | Price(3) |  | Weighted Average Remaining Contractual Term |  | Aggregate Intrinsic Value
Outstanding, January 1, 2018 | 4,110 |  |  | $ | 6.10 |  |  | 4.1 years |  | $ | 2,378 |
Granted (1) | 1 |  |  | 5.10 |  |  |  |  |
Exercised (2) | (31 | ) |  | 2.37 |  |  |  |  |
Forfeited | (26 | ) |  | 6.56 |  |  |  |  |
Expired | (809 | ) |  | 10.73 |  |  |  |  |
Outstanding, December 31, 2018 | 3,245 |  |  | 4.97 |  |  | 3.8 years |  | $ | 2,938 |
Exercisable | 2,822 |  |  | 5.10 |  |  | 3.4 years |  | $ | 2,915 |
Expected to vest | 423 |  |  | 4.15 |  |  | 6.6 years |  | $ | 23 |
(1) | The weighted average grant date fair value of CCOH options granted during the years ended December 31, 2018, 2017 and 2016 was $2.39, $2.04 and $2.82 per share, respectively.
(2) | Cash received from option exercises during the years ended December 31, 2018, 2017 and 2016 was $0.1 million, $0.2 million and $0.6 million, respectively. The total intrinsic value of the options exercised during the years ended December 31, 2018, 2017 and 2016 was $0.1 million, $0.2 million and $0.4 million, respectively.
(3) | Reflects the weighted average exercise price per share.
The following table presents a summary of the Company's stock options outstanding at and stock option activity during the year ended December 31, 2018 ("Price" reflects the weighted average exercise price per share):
(In thousands, except per share data) | Options |  | Price |  | Weighted Average Remaining Contractual Term
Outstanding, January 1, 2018 | 2,092 |  |  | $ | 35.09 |  |  | 2.6 years
Granted | — |  |  |  |  |  |
Exercised | — |  |  |  |  |  |
Forfeited | (529 | ) |  | 35.60 |  |  |
Expired | (872 | ) |  | 35.88 |  |  |
Outstanding, December 31, 2017 (1) | 691 |  |  | 33.70 |  |  | 2.8 years
Exercisable | 677 |  |  | 33.47 |  |  | 2.8 years
Expected to Vest | 14 |  |  | 44.87 |  |  | 2.1 years
(1) | Non-cash compensation expense has not been recorded with respect to 0.1 million shares as the vesting of these options is subject to performance conditions that have not yet been determined probable to meet.
Summary of Unvested Options and Changes | A summary of the Company's unvested options and changes during the year ended December 31, 2018 is presented below:
(In thousands, except per share data) | Options |  | Weighted Average Grant Date Fair Value
Unvested, January 1, 2018 | 543 |  |  | $ | 19.61 |
Granted | — |  |  |  |
Vested (1) | — |  |  |  |
Forfeited | (529 | ) |  | 18.94 |
Unvested, December 31, 2018 | 14 |  |  | 44.87 |
(1) | The total fair value of the options vested during the years ended December 31, 2018, 2017 and 2016 was $0.0 million, $0.0 million and $0.2 million, respectively.
A summary of CCOH’s unvested options at and changes during the year ended December 31, 2018 is presented below:
(In thousands, except per share data) | Options |  | Weighted Average Grant Date Fair Value
Unvested, January 1, 2018 | 718 |  |  | $ | 4.19 |
Granted | 1 |  |  | 2.39 |
Vested (1) | (274 | ) |  | 4.28 |
Forfeited | (22 | ) |  | 3.90 |
Unvested, December 31, 2018 | 423 |  |  | 4.15 |
(1) | The total fair value of CCOH options vested during the years ended December 31, 2018, 2017 and 2016 was $1.2 million, $1.6 million and $2.7 million, respectively.
Summary of Restricted Stock Outstanding and Restricted Stock Activity | The following table presents a summary of the Company's restricted stock outstanding and restricted stock activity as of and during the year ended December 31, 2018 (“Price” reflects the weighted average share price at the date of grant):
(In thousands, except per share data) | Awards |  | Price
Outstanding, January 1, 2018 | 6,219 |  |  | $ | 3.81 |
Granted | 70 |  |  | 0.52 |
Vested (restriction lapsed) | (627 | ) |  | 4.26 |
Forfeited | (403 | ) |  | 3.39 |
Outstanding, December 31, 2018 | 5,259 |  |  | 3.74 |
The following table presents a summary of CCOH’s restricted stock and restricted stock units outstanding at and activity during the year ended December 31, 2018 ("Price" reflects the weighted average share price at the date of grant):
(In thousands, except per share data) | Awards |  | Price
Outstanding, January 1, 2018 | 3,900 |  |  | $ | 5.61 |
Granted | 2,054 |  |  | 5.37 |
Vested (restriction lapsed) | (592 | ) |  | 8.09 |
Forfeited | (229 | ) |  | 5.64 |
Outstanding, December 31, 2018 | 5,133 |  |  | 5.23 |
Schedule of Assumptions Used to Calculate Fair Value of Options | The following assumptions were used to calculate the fair value of CCOH’s options on the date of grant:
| Years Ended December 31,
| 2018 |  | 2017 |  | 2016
Expected volatility | 44% |  | 42% |  | 42% – 44%
Expected life in years | 6.3 |  | 6.3 |  | 6.3
Risk-free interest rate | 2.76% |  | 2.12% |  | 1.12% – 1.41%
Dividend yield | —% |  | —% |  | —%
Schedule of Loss Per Share | The following table presents the computation of loss per share for the years ended December 31, 2018, 2017 and 2016:
(In thousands, except per share data) | Years Ended December 31,
| 2018 |  | 2017 |  | 2016
NUMERATOR: |  |  |  |  |
Net loss attributable to the Company – common shares | $ | (201,910 | ) |  | $ | (398,060 | ) |  | $ | (302,056 | )
DENOMINATOR: |  |  |  |  |
Weighted average common shares outstanding – basic | 85,412 |  |  | 84,967 |  |  | 84,569 |
Stock options and restricted stock(1): | — |  |  | — |  |  | — |
Weighted average common shares outstanding – diluted | 85,412 |  |  | 84,967 |  |  | 84,569 |
Net loss attributable to the Company per common share: |  |  |  |  |
Basic | $ | (2.36 | ) |  | $ | (4.68 | ) |  | $ | (3.57 | )
Diluted | $ | (2.36 | ) |  | $ | (4.68 | ) |  | $ | (3.57 | )
(1) | Outstanding stock options and restricted shares of 7.2 million, 8.3 million and 7.9 million for the years ended December 31, 2018, 2017 and 2016, respectively, were not included in the computation of diluted earnings per share because to do so would have been anti-dilutive.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=114867106&loc=d3e526-108580 + Details
Name: | us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested shares. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2) -URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e)(1) -URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2) -URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration